Eine Krankenschwester von einem Krankenhaus, das Frankreichs einzigen bestätigten Fall des SARS ähnlichen Coronavirus der bereits 18 Menschen getötet hat gab selbst zu möglicherweise selber infiziert zu sein, sagte die Französiche Gesundheitsbehörde am Freitag.

Die Weltgesundheitsorganisation (WHO) erhöhte die Zahl der bestätigten Fälle Weltweit zu 33 nachdem Saudi Arabien sagte, dass zwei Menschen die ins Krankenhaus eingeliefert wurden dort im April durch Laboranalyse bestimmt worden waren mit dem Virus infiziert zu sein…

Lesen Sie die ganze Geschichte HIER.

Nicht zuletzt ist die Entstehung eines neuartigen Coronavirus (nCoV)eine wietere Bedrohung von neuen Viren der wir bevorstehen. Da viele von diesen Viren mit dem Menschen von wilden Tieren überqueren, weil Menschen immer tiefer und tiefer in den natürlichen Lebensraum von vielen Kreaturen reingraben. Und wir leben in einer Zeit, wo jeder neue Virus weniger als 24 Stunden von überall auf der Erde entfernt ist.

GENTAUR biete Ihnen eine Vielzahl von RT-PCR Assays, ELISA Kits, cDNAs und anderen molekularen Reagenzien, die uns helfen eine schnelle Antwort auf alle diese kommenden Bedrohungen zu finden.

*ELISA Kits

DEIA1035SARS Coronavirus IgG ELISA Kit - 1912 EUR

DEIA1036SARS Coronavirus IgM ELISA Kit - 1912 EUR

DEIA1035/DEIA1036: Dieses Kit verwendet eine feste Phase, indirekte ELISA assay zum Nachweis von IgG/IgM antikörper gegen SARS Coronavirus in zweistufigen Inkubations Verfahren. Mikrotiter Streifen warden vorher mit Coronavirus Antigenen gereinigt.

*Recombinante virale Antigene

- SARS-Assoziierte Coronavirus E recombinantes Antigen a.a. 1-76., #00191-v – 830 euro

- SARS-Assoziierte Coronavirus Nucleocapsid recombinanest Antigen N a.a. 1-49., #00192-v – 830 euro

- SARS-Assoziierte Coronavirus Nucleocapsid recombinantes Antigen C a.a. 340-390., #00193-v – 830 euro

- SARS-Assoziierte Coronavirus M recombinantes Antigen a.a. 182-216., #00194-v– 830 euro

-  SARS-Associated Coronavirus Spike mosaic recombinantes Antigen S(N) a.a. 12-53/90-115/171-203., #00195-v – 830 euro

- SARS-Associated Coronavirus Spike mosaic recombinantes Antigen S(M) a.a. 408-470/540-573., #00196-v – 830 euro

- SARS-Associated Coronavirus Spike mosaic recombinantes Antigen S© a.a. 1051-1076/1121-1154/1162-1190., #00197-v – 830 euro

Antikörper:

- Maus Monoklonal Anti-Mensch schweree akutes respiratorisches Syndrom (SARS-E2) Spezies Reactivität: menschlicher Coronavirus, #MA-20018,- 459 euro

- Maus Monoklonal Anti-Mensch schweres akutes respiratorosches Syndrom (SARS)-M Species Reactivity: menschlicher Coronavirus, # MA-20018, - 459 euro

- Anti-SARS Spitzenprotein IgG Spezies Reactivität: SARS, #AB-15710, - 433 euro

- Maus Anti-SARS Nucleocapsidprotein IgG Species Reactivität: MAUS, #AB-17810, - 498 euro

- Maus Anti-SARS Spike IgG Spezies Reactivität: MAUS, #AB-17910, - 498 euro

- Anti-SARS Nucleocapsidprotein IgG Spezies Reactivität: SARS, #AB-18010, - 498 euro

Recombinantes SARS-ACSM Antigen kann in ELISA und Western Blots verwendet werden, hervorragend für den Nachweis von SARS mit minimalen Spezifität Problemen!

SARS-ACSMS(M) (Reste 408-470, 540-573) SARS-Assoziiertes Coronavirus Spike Mosaic S(M)recombinant, E. Coli, #PR-1106, - 194 euro

SARS-ACSMS(C) (Reste 1051-1076, 1121-1154, 1162-1190) SARS-Assoziiertes Coronavirus Spike Mosaic S(C)recombinant, E. Coli, #PR-1105, -194 euro

SARS-ACN/3 (Reste 1-49, 192-220) SARS-Assoziiertes Coronavirus Nucleocapsid recombinant, E. Coli, #PR-1104 - 194 euro

SARS-ACN/2 (Reste 1-49) SARS-Assoziiertes Coronavirus Nucleocapsid recombinant, E. Coli, #PR-1103, - 194 euro

SARS-ACN/1 (Reste 340-390) SARS-Assoziiertes Coronavirus Nucleocapsid recombinant, E. Coli,PR-1102, - 194 euro

SARS-ACM (Reste 182-216) SARS-Assoziiertes Coronavirus Matrix rekombinant, E. Coli PR-1101,- 194 euro

SARS-ACE (Reste 1-76) SARS-Assoziiertes Coronavirus Umschlags rekombinant, E. Coli,PR-1100, - 194 euro

*Menschliches SARS cDNA Klon

Menschliches SARS cDNA klon, 10 g, Orf Größe: 1545, Vektor: pcDNA4/TO/myc-His A, # DC00346–  181 euro

A nurse in a hospital that held France's only confirmed case of the SARS-like coronavirus that has killed 18 people has been admitted to hospital in northern France on suspicion on being infected herself, French health officials said on Friday.

The World Health Organisation (WHO) raised the number of cases confirmed worldwide to 33 after Saudi Arabia said that two people who were admitted to hospital there in April had been determined by laboratory analysis to be infected.

There is no evidence so far of sustained human-to-human transmission of the coronavirus. But health experts are concerned about clusters of new possible cases of nCoV, which started in the Gulf and spread to France, Britain and Germany.

Two people who had contact with the confirmed French case, a 65-year-old man who fell ill on returning from Dubai, were admitted to hospital late on Thursday.

One was a patient who shared a ward with him when he was in a hospital in the town of Valenciennes, northern France, at the end of April, and the other is a doctor who treated him there.

The 65-year-old, who is in stable but serious condition, was transferred to an isolated intensive care wing in Douai near Lille, which is where the third case appeared. He was transferred to Lille on Thursday night.

"We identified it overnight. It corresponds to the investigations we've been undertaking since our confirmed case of the coronavirus," said Sandrine Kueny, deputy director of the regional health agency.

The nurse worked in the hospital's infectious disease unit but it was unclear whether she had direct contact with the sick man.

The coronavirus is from the same viral family that triggered the outbreak of Severe Acute Respiratory Syndrome (SARS) that swept the world after starting in Asia in late 2003 and killed 775 people.

Giving details of the two new Saudi cases, Saudi deputy health minister Ziad Memish said in an email to the web-based disease monitoring system ProMED that a study of earlier reported cases and repeat testing of suspected cases had identified two additional cases on May 8.

The first patient was a 48-year-old man with multiple coexisting medical conditions who became ill on April 29. He was in stable condition, the WHO said.

The second patient was a 58-year-old man with an existing medical condition who became ill on April 6. He fully recovered and was discharged from hospital on May 3.

Memish added in the email that actions taken by Saudi authorities since May 1 had prevented new cases emerging.

Since the beginning of May, 15 patients have been reported from the Saudi outbreak, of which seven had died, the WHO said. Of the 15 patients, 12 were men and three women. The age range of the patients are from 24 to 94 years old.

French authorities advise that anyone who has recently traveled to the Gulf region consult a doctor in case of fever.

Related products: